Glanzmann's thrombasthenia

from Wikipedia, the free encyclopedia
Classification according to ICD-10
D69.1 Qualitative platelet
defects - Glanzmann (Naegeli) syndrome
ICD-10 online (WHO version 2019)

The Glanzmann's thrombasthenia (or Glanzmann-Naegeli syndrome , Crohn Glanzmann-Naegeli by Eduard Glanzmann , Swiss pediatrician 1887-1959) is a rare inherited platelet function leading to a greatly increased tendency to bleed can result. The term hereditary thrombasthenia is also used synonymously .

It is triggered by defects in the genes (17q 21) for GPIIb or GPIIIa. As a result, the GPIIb / GPIIIa receptor on platelets is defective or absent, resulting in poor aggregation of platelets (as occurs in primary hemostasis). In addition, the adhesion to Von Willebrand factor and fibronectin , which, in addition to the platelet-crosslinking fibrinogen , are bound by the activated GPIIb / IIIa receptor, is disturbed .

A knock-out of one of the two genes in mice leads to a Glanzmann-like phenotype in the animals.

The autosomal dominant macrothrombocytopenia can thrombasthenia Glanzmann be regarded as a special form of.

On September 18, 2014, a group of American and Indian researchers were awarded the Ig Nobel Prize for documenting the hemostatic effect of cured pork on Glanzman's thrombasthenia. The Glanzmann thrombasthenia can be proven by a functional examination of the platelets ( light transmission aggregometry ).

literature

Web links

Individual evidence

  1. ^ W. Pschyrembel: Clinical dictionary. Verlag Walter de Gruyter, 265th edition (2014), p. 1666, ISBN 3-11-018534-2
  2. ^ Awarding of the Ig Nobel Prizes. Mirror online
  3. Nasal packing with strips of cured pork as treatment for uncontrollable epistaxis in a patient with Glanzmann thrombasthenia . PMID 22224315